Endoscopic Screening of Barrett's Esophagus

Area of Science:

• Gastroenterology and Endoscopy
• Oncology
• Preventive Medicine

Background:

• Barrett's esophagus (BE) is a premalignant condition.
• Early detection of BE and its associated dysplasia or esophageal adenocarcinoma (EAC) is crucial for effective management.
• Risk factors for BE include chronic reflux, age, male sex, Caucasian race, smoking, obesity, hiatal hernia, and family history.

Purpose of the Study:

• To outline the importance of endoscopic screening for Barrett's esophagus (BE).
• To highlight the role of endoscopic surveillance in detecting dysplasia and esophageal adenocarcinoma (EAC).
• To identify key risk factors and diagnostic methods for BE.

Main Methods:

• High-definition endoscopy with targeted biopsies.
• Precise identification of anatomical landmarks during endoscopy.
• Assessment of patient risk factors for BE development.

Main Results:

• Endoscopic screening facilitates the detection of premalignant changes in BE.
• Endoscopic therapy can effectively manage BE dysplasia and early-stage EAC, reducing cancer risk.
• Risk prediction tools for BE are under development.

Conclusions:

• Endoscopic screening and surveillance are vital for managing Barrett's esophagus and preventing esophageal adenocarcinoma.
• Identifying individuals with multiple risk factors is essential for targeted screening.
• Advancements in endoscopic technology improve diagnostic accuracy for BE.